Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cells

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 129-135

  Dong, Xin ^a   An, Bing ^a   Kierstead, Lisa Salvucci ^a   Storkus, Walter J ^a   Amoscato, Andrew A ^a,b   Salter, Russell D ^a,c  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; BESTATIN; HLA DR4 ANTIGEN; HUMAN IMMUNOGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; PROTEINASE INHIBITOR; SYNTHETIC PEPTIDE;

AMINO TERMINAL SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYBRIDOMA; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; T LYMPHOCYTE;

EID: 0033961824     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.129     Document Type: Article

References (45)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down-regulation by cytokines and bacterial products. J. Exp. Med. 182:389.
3. Steinman, R. M., and J. Swanson. 1995. The endocytic activity of dendritic cells J. Exp. Med. 182:283.
4. Cella, M., F. Sallusto, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10.
5. 3, integrin and requires intracellular and extracellular calcium. Eur. J. Immunol. 27:1893.
6. Prigozy, T. I., P. A. Sieling, D. Clemens, P. L. Stewart, S. M. Behar, S. A. Porcelli, M. B. Brenner, R. L. Modlin, and M. Kronenberg. 1997. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6:187.
7. Engering, A. J., M. Cella, D. M. Fluitsma, M. Brockhaus, E. C. Hoefsmit, A. Lanzavecchia, and J. Pieters. 1997. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 27:2417.
8. Tan, M. C., A. M. Mommaas, J. W. Drijfhout, R. Jordens, J. J. W. Onderwater, D. Verwoerd, A. A. Mulder, A. N. van der Heiden, D. Scheidegger, L. C. Oomen, et al. 1997. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 27:2426.
9. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1359.
10. Regnault, A., D. Lankar, V. Lacabanne, A. Rodriguez, C. Thery, M. Rescigno, T. Saito, S. Verbeek, C. Bonnerot, M. Rescigno, et al. 1998. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188:2175.
11. Rovere, P., C. Vallinoto, A. Bondanza, M. C. Crosti, M. Rescigno, P. Ricciardi-Castagnoli, C. Rugarli, and A. A. Manfredi. 1998. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J. Immunol. 161:4467.
12. Winzler C., P. Rovere, V. S. Zimmermann, J. Davoust, M. Rescigno, S. Citterio, and P. Ricciardi-Castagnoli. 1997. Checkpoints and functional stages in DC maturation. Adv. Exp. Med. Biol. 417:59.
13. Lutz, M. B., P. Rovere, M. J. Kleijmeer, M. Rescigno, C. U. Assmann, V. M. Oorschot, H. J. Geuze, J. Trucy, D. Demandolx, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Intracellular routes and selective retention of antigens in mildly acidic cathepsin D/lysosome-associated membrane protein-I/MHC class II-positive vesicles in immature dendritic cells. J. Immunol. 159: 3707.
14. Regnault, A., D. Lankar, V. Lacabanne, A. Rodriguez, C. Thery, M. Rescigno, T. Saito, S. Verbeek, C. Bonnerot, P. Ricciardi-Castagnoli, and S. Amigorena. 1999. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:371.
15. Buelens, C., V. Verhasselt, D. De Groote, K. Thielemans, M. Goldman, and F. Willems. 1997. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin. Eur. J. Immunol. 27: 1848.
16. Verhasselt, V., C. Buelens, F. Willems, D. De Groote, N. Haeffner-Cavaillon, and M. Goldman. 1997. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J. Immunol. 158:2919.
17. Morel, A. S., S. Quaratino, D. C. Douek, and M. Londei. 1997. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur. J. Immunol. 27:26.
18. Poggi, A., E. Tomasello, E. Ferrero, M. R. Zocchi, and L. Moretta. 1998. p40/LAIR-1 regulates the differentiation of peripheral blood precursors to dendritic cells induced by granulocyte-monocyte colony-stimulating factor. Eur. J. Immunol. 28:2086.
19. Randolph, G. J., S. Beaulieu, S. Lebecque, R. M. Steinman, and W. A. Muller. 1998. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282:480.
20. Wilson, C.C., W. C. Olson, T. Tuting, C. R. Rinaldo, M. T. Lotze, and W. J. Storkus. 1999. HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines. J. Immunol. 162:3070.
21. Tjandrawan, T., D. Martin, M. J. Maeurer, C. Castelli, M. T. Lotze, and W. J. Storkus. 1998. Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro. J. Immunother. 21: 149.
22. Zitvogel, L., J. I. Mayordomo, T. Tjandrawan, A. B. DeLeo, M. R. Clarke, M. T. Lotze, and W. J. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells. B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183:87.
23. Celluzzi, C. M., J. I. Mayordomo, W. J. Storkus, M. T. Lotze, and L. D. Falo, Jr. 1996. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183:283.
24. Amoscato, A. A., D. A. Prenovitz, and M. T. Lotze. 1998. Rapid extracellular degradation of synthetic class I peptides by human dendritic cells. J. Immunol. 161:4023.
25. Woods, A., H. Y. Chen, M. E. Trumbaue, A. Sirotina, R. Cummings, and D. M. Zaller. 1994. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J. Exp. Med. 180:173.
26. Kovats, S., P. E. Whitely, P. Concannon, A. Y. Rudensky, and J. S. Blum. 1997. Presentation of abundant endogenous class II DR-restricted antigens by DM-negative B cell lines. Eur. J. Immunol. 27:1014.
27. Denzin, L. K., N. F. Robbins, C. Carboy-Newcomb, and P. Cresswell. 1994. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1:595.
28. Rammensee, H. G., T. Friede, and S. Stevanoviic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
29. Balog, T., T. Marotti, M. Abramic, I. Svoboda-Beusen, and I. Hrsak. 1999. The role of aminopeptidase N in Met-enkephalin modulated superoxide anion release. Immunopharmacology 41:11.
30. Stefanovic, V., P. Vlahovic, and M. Mitic-Zlatkovic. 1998. Epidermal growth factor up-regulates aminopeptidase N and 5′-nucleotidase in human glomerular mesangial cells. Kidney Blood Press. Res. 21:310.
31. Ashmun, R. A., and A. T. Look. 1990. Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood 75:462.
32. Look, A. T., R. A. Ashmun, L. H. Shapiro, and S. C. Peiper. 1989. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J. Clin. Invest. 83:1299.
33. Ramakrishnan, L., Q. Wu, A. Yue, M. D. Cooper, and N. Rosenberg. 1990. BP-1/6C3 expression defines a differentiation stage of transformed pre-B cells and is not related to malignant potential. J. Immunol. 145:1603.
34. Wu, Q., J. M. Lahti, G. M. Air, P. D. Burrows, and M. D. Cooper. 1990. Molecular cloning of the murine BP-1/6C3 antigen: a member of the zinc-dependent metallopeptidase family. Proc. Natl. Acad. Sci. USA 87:993.
35. Amoscato, A. A., J. W. Alexander, and G. F. Babcock. 1989. Surface aminopeptidase activity of human lymphocytes. I. Biochemical and biologic properties of intact cells. J. Immunol. 142:1245.
36. Amoscato, A. A., R. M. Sramkoski, G. F. Babcock, and J. W. Alexander. 1990. Neutral surface aminopeptidase activity of human tumor cell lines. Biochim. Biophys. Acta 104:317.
37. Menrad, A., D. Speicher, J. Wacker, and M. Herlyn. 1993. Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res. 53:14.50.
38. Saiki, L. H. Fujii, J. Yoneda, F. Abe, M. Nakajima, T. Tsuruo, and I. Azuma. 1993. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int. J. Cancer 54:137.
39. Kanayama, N., Y. Kajiwara, J. Goto, E. el Maradny, K. Maehara, K. Andou, and T. Terao. 1995. Inactivation of interleukin-8 by aminopeptidase N (CD13). J. Leukocyte Biol. 57:129.
40. Yeager, C. L., R. A. Ashmun, R. K. Williams, C. B. Cardellichio, L. H. Shapiro, A. T. Look, and K. V. Holmes. 1992. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357:420.
41. Giugni, T. D., C. Soderberg, D. J. Ham, R. M. Bautisia, K. O. Hedlund, E. Moller, and J. A. Zaia. 1996. Neutralization of human cytomegalovirus by human CD13-specific antibodies. J. Infect. Dis. 173:1062.
42. Mouritsen, S., M. Meldal, O. Werdelin, A. Stryhn Hansen, and S. Buus. 1992. MHC molecules protect T cell epitopes against proteolytic destruction. J. Immunol. 149:1987.
43. Larsen, S. L., L. O. Pedersen, S. Buus, and A. Stryhn. 1996. T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides. J. Exp Med. 184:183.
44. Allen, P. M., G. R. Matsueda, S. Adams, J. Freeman, R. W. Roof, L. Lambert, and E. R. Unanue. 1989. Enhanced immunogenicity of a T cell imniunogenic peptide by modifications of its N and C termini. Int. Immunol. 1:141.
45. Bouvier, M., and D. C. Wiley. 1994. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 265:398.